Cambridge Capital Group has a live portfolio of more than 50 investments in the following sectors: medtech/life sciences, software and digital, electronics and wireless communications, specialist engineering and semiconductors, agritech and food, cleantech.

Our members have enjoyed several profitable exits including the following companies, delivering returns of between 2X and 15X.

Bango: “Mobile payments platform. AIM listing” Mobile payments platform. AIM listing
ITM Power: “Fuel cell technology. AIM listing” Fuel cell technology. AIM listing
DanioLabs: “Drug discovery screening. Sale to AIM listed Summit Plc.” Drug discovery screening. Sale to AIM listed Summit Plc.
Ubisense: “Real-time location tracking for manufacturing. AIM listing” Real-time location tracking for manufacturing. AIM listing
Phonetic arts: “Speech generation engine for computer games. Sale to Google” Speech generation engine for computer games. Sale to Google
Swiftkey: “Predictive text input for smartphones. Sale to Microsoft for $250m.” Predictive text input for smartphones. Sale to Microsoft for $250m.
Cambridge CMOS Sensors: “Micro technology for gas sensors. Sold to Austrian Microsystems” Micro technology for gas sensors. Sold to Austrian Microsystems
Expedeon: “Proteomics reagents and tools. Merged with quoted Sygnis AG” Proteomics reagents and tools. Merged with quoted Sygnis AG
Oval Medical Technologies: “Speciality autoinjector developer sold to US based SMC”. Speciality autoinjector developer sold to US based SMC

Cambridge cluster

The Cambridge technology cluster has developed rapidly over the last two decades and now forms a significant community of innovation-based businesses which provide exciting opportunities for private investors who have access to the market via specialist networks such as Cambridge Capital Group.

Cambridge cluster